Loading
Taste Movie

Taste Movie 2015

News

Mersana's cancer drug trial put on hold by FDA; shares halted

(Reuters) – Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on partial hold by the U.S. Food and Drug Administration after a patient’s death was possibly linked to the treatment. No…..

More U.S. teens saying 'no' to smoking and drinking

(Reuters Health) – High school students in the U.S. are a lot more sober than they used to be, a new study suggests. The proportion of high school students in their final year who have never tried alcohol or drugs…..

Bulgaria reports another case of ovine rinderpest

SOFIA (Reuters) – Bulgaria reported on Thursday another case of the highly contagious Peste des Petits Ruminants (PPR) close to the border with Turkey. The virus, which can infect up to 90 percent of an animal heard but does not…..

Allergan, Molecular Partners eye drug meets main goal in two studies

(Reuters) – Allergan Plc and Molecular Partners AG said on Thursday their treatment for neovascular age-related macular degeneration, a leading cause of vision loss among people over 65, met the main goal in two late-stage studies. FILE PHOTO: The Allergan…..

Trump thanks Novartis, Pfizer for not raising drug prices

WASHINGTON (Reuters) – U.S. President Donald Trump on Thursday thanked two major drug companies for not raising their prices and said his administration was working toward “substantially” cutting prescription-drug prices. FILE PHOTO: U.S. President Donald Trump walks from Marine One…..

Roche takes Tecentriq hit on survival data

ZURICH (Reuters) – Roche’s hopes of clinching more of the lung cancer treatment market with its Tecentriq immunotherapy had a major setback on Thursday, when a trial failed to deliver survival data the Swiss drugmaker needs to challenge rival Merck……

Roche still awaiting Tecentriq survival data in key study

ZURICH (Reuters) – Roche’s Tecentric immunotherapy mixed with chemotherapy has not yet achieved a hoped-for overall survival target in first-line lung cancer treatment, the Swiss drugmaker said on Thursday. FILE PHOTO: The logo of Swiss pharmaceutical company Roche is pictured…..

Novartis to pay 95 million euros to Galapagos, MorphoSys for skin drug

ZURICH (Reuters) – Novartis said on Thursday it will pay 95 million euros ($ 110.49 million) to Galapagos and MorphoSys to license a prospective medicine targeting the skin condition atopic dermatitis, as the Swiss drugmaker strengthens its foothold in immunology……

AngioDynamics to pay $12.5 million over false claims allegations: U.S. Justice Department

WASHINGTON (Reuters) – AngioDynamics Inc has agreed to pay the U.S. government $ 12.5 million to resolve allegations it caused healthcare providers to submit false claims to federal healthcare programs over the use of two medical devices, the Justice Department…..

More evidence that omega-3 supplements lack heart benefits

(Reuters Health) – Omega-3 fatty acids have long been touted as heart healthy, but taking them in supplement form does little to protect against heart disease, a large new analysis suggests. The study combined data from 112,059 patients who took…..